LXH254
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LXH254, covering 2025-04-13 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma [Phase 2]